Mylan N.V. (MYL) PT Set at $42.00 by Citigroup Inc.
Mylan N.V. (NASDAQ:MYL) received a $42.00 price objective from analysts at Citigroup Inc. in a research report issued to clients and investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Citigroup Inc.’s target price points to a potential upside of 10.76% from the company’s current price.
MYL has been the subject of several other research reports. Cantor Fitzgerald started coverage on shares of Mylan N.V. in a research report on Friday, June 16th. They set a “neutral” rating and a $41.00 price target for the company. Royal Bank Of Canada set a $41.00 price target on shares of Mylan N.V. and gave the company a “hold” rating in a research report on Sunday, July 16th. BidaskClub raised shares of Mylan N.V. from a “strong sell” rating to a “sell” rating in a research report on Thursday, September 7th. Cowen and Company reaffirmed a “hold” rating and set a $43.00 price target on shares of Mylan N.V. in a research report on Thursday, August 3rd. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $45.00 price target on shares of Mylan N.V. in a research report on Friday, September 29th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $42.04.
Shares of Mylan N.V. (MYL) traded up 0.32% during trading on Wednesday, reaching $37.92. 11,211,385 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $31.86 and a 200 day moving average price of $36.48. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $45.87. The firm has a market cap of $20.34 billion, a price-to-earnings ratio of 30.65 and a beta of 1.30. Mylan N.V. also was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 10,562 put options on the stock. This is an increase of approximately 461% compared to the average daily volume of 1,883 put options.
Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.18 by ($0.08). Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The business had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3 billion. During the same period in the previous year, the company earned $1.16 EPS. Mylan N.V.’s revenue for the quarter was up 15.7% compared to the same quarter last year. On average, analysts forecast that Mylan N.V. will post $4.52 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Mylan N.V. (MYL) PT Set at $42.00 by Citigroup Inc.” was reported by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/10/05/mylan-n-v-myl-pt-set-at-42-00-by-citigroup-inc.html.
A number of hedge funds have recently bought and sold shares of MYL. Waldron LP bought a new position in Mylan N.V. in the 1st quarter worth approximately $229,000. UBS Asset Management Americas Inc. boosted its stake in Mylan N.V. by 13.7% in the 1st quarter. UBS Asset Management Americas Inc. now owns 1,179,217 shares of the company’s stock worth $45,978,000 after purchasing an additional 142,124 shares during the period. Sei Investments Co. boosted its stake in Mylan N.V. by 1.0% in the 1st quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock worth $541,000 after purchasing an additional 134 shares during the period. Blair William & Co. IL boosted its stake in Mylan N.V. by 20.3% in the 1st quarter. Blair William & Co. IL now owns 9,591 shares of the company’s stock worth $401,000 after purchasing an additional 1,616 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in Mylan N.V. by 4.3% in the 1st quarter. Alliancebernstein L.P. now owns 822,534 shares of the company’s stock worth $32,071,000 after purchasing an additional 33,666 shares during the period. Institutional investors and hedge funds own 71.97% of the company’s stock.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.